Latur Medichem Profile
Key Indicators
- Authorised Capital ₹ 0.30 M
as on 04-07-2024
- Paid Up Capital ₹ 0.30 M
as on 04-07-2024
- Company Age 23 Year, 10 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 5.85 M
as on 04-07-2024
- Revenue 13.21%
(FY 2022)
- Profit -2950.00%
(FY 2022)
- Ebitda -188.96%
(FY 2022)
- Net Worth -29.88%
(FY 2022)
- Total Assets 32.56%
(FY 2022)
About Latur Medichem
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.30 M and a paid-up capital of Rs 0.30 M.
The company currently has active open charges totaling ₹5.85 M.
Nitin Avate, Atul Gund, Vinay Mohan, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24231MH2001PTC130985
- Company No.
130985
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
23 Feb 2001
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Latur, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Latur Medichem?
Board Members(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Nitin Avate | Additional Director | 22-Nov-2021 | Current |
Atul Gund | Additional Director | 22-Nov-2021 | Current |
Vinay Mohan | Additional Director | 22-Nov-2021 | Current |
Sandeep Shah | Additional Director | 22-Nov-2021 | Current |
Apurva Shah | Additional Director | 22-Nov-2021 | Current |
Financial Performance of Latur Medichem.
Latur Medichem Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 13.21% increase. The company also saw a substantial fall in profitability, with a 2950% decrease in profit. The company's net worth observed a substantial decline by a decrease of 29.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Latur Medichem?
In 2022, Latur Medichem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Ruby Ailcare Services Private LimitedActive 19 years 6 months
Sandeep Shah and Apurva Shah are mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 29 Nov 2019 | ₹5.85 M | Open |
How Many Employees Work at Latur Medichem?
Unlock and access historical data on people associated with Latur Medichem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Latur Medichem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Latur Medichem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.